1 The World Health Organization has estimated that in 2021, higher-than-optimal body mass index (BMI) caused an estimated 3.7 million deaths from noncommunicable diseases such as cardiovascular diseases, diabetes, cancers, neurological disorders, chronic respiratory diseases, and digestive disorders
As researchers continue to study the ways GLP-1 receptor agonists influence sleep, there is growing optimism that these medications could reshape the treatment landscape for OSA and beyond
Research continues to teach us more
These figures should be interpreted in the context of a controlled trial population
While this medication is getting a lot of attention, it comes with benefits and potential risks
Journal of Clinical Medicine, 11(3), 5915